This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medimmune Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Lutz Ulrich Jochen Wilhelm Jermutus: Innovator in Protein Variants
Introduction
Lutz Ulrich Jochen Wilhelm Jermutus is a notable inventor based in Granta Park, GB. He has made significant contributions to the field of biotechnology, particularly in the development of protein variants that have therapeutic potential. His work focuses on enhancing the activity and stability of CTLA-4 protein variants.
Latest Patents
Lutz holds a patent for CTLA-4 protein variants. These variants demonstrate increased activity compared to the wild-type in cell assays and exhibit enhanced stability. Such innovations are crucial for treating disorders where the attenuation of the T cell response is beneficial. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Lutz is currently associated with MedImmune Limited, a leading biotechnology company. His role involves research and development aimed at creating advanced therapeutic solutions. His work has positioned him as a key figure in the field of immunology and protein engineering.
Collaborations
Lutz has collaborated with notable colleagues, including Ruth Franks and Mark Terence Liddament. These partnerships have contributed to the advancement of his research and the successful development of innovative protein variants.
Conclusion
Lutz Ulrich Jochen Wilhelm Jermutus is a distinguished inventor whose work on CTLA-4 protein variants has the potential to impact therapeutic strategies significantly. His contributions to biotechnology continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
